Phoenixville Hospital, LLC
Phoenixville Hospital, LLC was paid $4.61M by Medicaid between Aug 2019 and Dec 2024, across 85 billing codes. Its largest line is 99284, emergency room visit (serious) — 43% of everything it billed.
33Billing provider infoPHOENIXVILLE HOSPITAL, LLC
PHOENIXVILLE, PA 19460
PHOENIXVILLE, PA 19460
33aNPI1750805552assigned 08/02/2017
33bProvider typeSpeech-Language Pathologist
28Total paid$4.61M
24GClaims45,992
24DCodes billed85
24AFirst – last monthAug 2019 – Dec 2024
Compared with peers
Next to other Speech-Language Pathologist providers in Pennsylvania
Rank by total paid#2 of 253
Median peer was paid$34K
This provider vs. median137×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RAYME, BRIAN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 1,516 | $173K | |
| 2020 | 9,390 | $899K | |
| 2021 | 16,596 | $1.42M | |
| 2022 | 4,469 | $881K | |
| 2023 | 7,981 | $846K | |
| 2024incomplete | 6,040 | $386K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 43% | 8,058 | 7,726 | $2.00M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 6,383 | 6,224 | $1.61M |
| G0378 | Hospital observation service, per hour | 9.6% | 432 | 399 | $441K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.0% | 940 | 858 | $186K |
| X0621 | 1.7% | 275 | 211 | $79K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 280 | 277 | $72K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 299 | 295 | $35K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 232 | 225 | $32K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,103 | 3,505 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 2,457 | 2,175 | $11K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 300 | 295 | $9K |
| 76830 | Ultrasound, transvaginal | <1% | 141 | 137 | $9K |
73 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 246 | $7K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 86 | $7K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 207 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,384 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 190 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 101 | $5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 175 | $5K |
| 87631 | <1% | 83 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 349 | $5K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 249 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 367 | $5K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $4K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 83 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 268 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 610 | $3K |
| 84484 | <1% | 717 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 30 | $3K |
| 76642 | <1% | 43 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 535 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,464 | $2K |
| 84703 | <1% | 296 | $2K | |
| 83735 | <1% | 673 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 551 | $1K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $1K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 108 | $1K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 61 | $1K |
| 81001 | <1% | 695 | $1K | |
| 72110 | <1% | 41 | $1K | |
| 85610 | <1% | 456 | $956.86 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 222 | $759.47 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 378 | $705.06 |
| 82248 | <1% | 268 | $698.39 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 33 | $698.11 |
| J3490 | Unclassified drugs | <1% | 564 | $644.32 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 91 | $596.13 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,547 | $530.03 |
| 85730 | <1% | 173 | $517.54 | |
| 83690 | <1% | 247 | $511.95 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 493 | $503.27 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $460.91 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 93 | $432.83 |
| J2704 | Injection, propofol, 10 mg | <1% | 519 | $414.60 |
| 73564 | <1% | 12 | $371.18 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 14 | $338.03 |
| 83880 | <1% | 41 | $317.18 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 327 | $233.71 |
| 82550 | <1% | 66 | $220.03 | |
| 73630 | <1% | 28 | $215.11 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 30 | $213.03 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 970 | $199.69 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 853 | $184.59 |
| 86900 | <1% | 54 | $177.15 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,246 | $173.20 |
| 73030 | <1% | 13 | $170.76 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 281 | $146.78 |
| 82962 | <1% | 181 | $136.09 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 27 | $107.54 |
| 81003 | <1% | 99 | $105.14 | |
| 86901 | <1% | 27 | $71.95 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 289 | $66.74 |
| 85379 | <1% | 29 | $63.60 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 255 | $63.52 |
| 94760 | <1% | 64 | $46.25 | |
| 83605 | <1% | 14 | $26.88 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 131 | $13.59 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 152 | $12.25 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 18 | $9.11 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 58 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 173 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 14 | $0.00 |
| 00000 | 0% | 861 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 15 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAYME, BRIAN (EVP & CFO)
| Provider | Location | Paid |
|---|---|---|
| STC Opco LLC | Philadelphia, PA | $69.20M |
| Tower Health Urgent Care, LLC | Douglassville, PA | $11.77M |
| Pottstown Hospital, LLC | Pottstown, PA | $7.54M |
| Pottstown Clinic Company LLC | Pottstown, PA | $2.96M |
| Tower Drexel Academic Medical Group LLC | Philadelphia, PA | $2.47M |
| STC Opco LLC | Philadelphia, PA | $2.06M |
| STC Pediatrics LLC | Philadelphia, PA | $2.06M |
| STC Pediatrics LLC | Philadelphia, PA | $1.73M |
| Phoenixville Clinic Company LLC | Phoenixville, PA | $1.68M |
| STC Pediatrics LLC | Philadelphia, PA | $1.48M |
| STC Pediatrics LLC | Philadelphia, PA | $1.31M |
| Tower Health Medical Group | Wyomissing, PA | $1.28M |
| STC Pediatrics LLC | Philadelphia, PA | $988K |
| Tower Health Medical Group | West Reading, PA | $850K |
| Tower Health Medical Group | West Reading, PA | $724K |
| Tower Health Medical Group | West Reading, PA | $720K |
| Tower Health Medical Group | Birdsboro, PA | $543K |
| STC Pediatrics LLC | Philadelphia, PA | $497K |
| STC Pediatrics LLC | Philadelphia, PA | $462K |
| STC Pediatrics LLC | Philadelphia, PA | $449K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.